Company Search:
Advanced Search
Sponsored Links
Genmab A/S Company Snapshot
Genmab A/S operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Genmab A/S with three other miscellaneous service companies in Europe: Pharma Mar SA of Spain (2016 sales of 180.95 million Euro [US$224.50 million] of which 62% was Biotech Sector), AddLife AB of Sweden (1.98 billion Swedish Kronor [US$248.10 million] of which 63% was LabTech), and Bachem Holding AG which is based in Switzerland (236.48 million Swiss Francs [US$254.55 million] of which 89% was Active Pharmaceutical Ingredients).

Sales Analysis. Genmab A/S reported sales of 1.82 billion Danish Kroner (US$302.58 million) for the year ending December of 2016. This represents an increase of 60.3% versus 2015, when the company's sales were 1.13 billion Danish Kroner. Sales at Genmab A/S have increased during each of the previous five years (and since 2011, sales have increased a total of 418%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Genmab A/S
  Stock Performance Chart for Genmab A/S
  Stock Data: Recent Stock Performance:
  Current Price (2/16/2018): 1,088.00
(Figures in Danish Kroner)
1 Week 4.9%   13 Weeks -7.0%  
4 Weeks -11.2%   52 Weeks -22.7%  
Genmab A/S Key Data:
  Ticker: GEN Country: Denmark
  Exchanges: CPH Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 1,816,122,000
(Year Ending Jan 2017).
Employees: 205
  Currency: Danish Kroner Market Cap: 66,436,698,496
  Fiscal Yr Ends: December Shares Outstanding: 61,063,142
  Share Type: Stammaktie Closely Held Shares: 2,834,715
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.